InMed Pharmaceuticals News

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
InMed Pharmaceuticals Inc INM NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.05 -1.75% 2.80 09:35:41
Open Price Low Price High Price Close Price Prev Close
2.85 2.80 2.85 2.85
more quote information »

Recent News

Date Time Source Heading
7/29/202111:00IHNWFeaturedEmerging Markets Report: Catching Up with Liberty Defense
7/23/202106:05EDGARNotice of Effectiveness (effect)
7/19/202106:14EDGARSmall Company Offering and Sale of Securities Without..
7/13/202106:01EDGARSecurities Registration Statement (s-1)
7/02/202116:28EDGARCurrent Report Filing (8-k)
7/02/202116:15GLOBEInMed Pharmaceuticals Announces Closing of US$12 Million..
6/30/202106:01EDGARCurrent Report Filing (8-k)
6/29/202115:13EDGARCurrent Report Filing (8-k)
6/29/202107:42SEEKInMed Pharma signs LOI to acquire rare cannabinoids..
6/29/202107:31SEEKInMed Pharma shares climb on launch of $12M private..
6/29/202107:00GLOBEInMed Pharmaceuticals Signs Non-binding Letter of Intent to..
6/28/202108:35GLOBELife Sciences Companies Investor Presentations Now Available..
6/23/202106:01EDGARCurrent Report Filing (8-k)
6/22/202112:29GLOBEInMed Pharmaceuticals to Webcast Live at Life Sciences..
6/21/202108:35GLOBEVirtual Conference for Life Sciences Companies Broadcast..
6/17/202113:20EDGARCurrent Report Filing (8-k)
6/17/202107:30GLOBEInMed Pharmaceuticals Increases Cannabinoid Yield to 5 g/L..
6/09/202111:30EDGARCurrent Report Filing (8-k)
6/09/202111:30GLOBEInMed Pharmaceuticals to Present at the 2021 BIO Digital..
5/13/202116:25EDGARCurrent Report Filing (8-k)
5/13/202107:34SEEKInMed Pharmaceuticals reports FQ3 results
5/13/202107:30GLOBEInMed Pharmaceuticals Reports Third Quarter Fiscal 2021..
5/06/202107:30EDGARCurrent Report Filing (8-k)
5/06/202107:30GLOBEInMed Pharmaceuticals to Report Third Quarter Fiscal 2021..
5/04/202107:30GLOBEInMed to Present at Canaccord Genuity’s 5th Annual Global..
4/28/202113:32EDGARCurrent Report Filing (8-k)
4/28/202111:45EDGARCurrent Report Filing (8-k)
4/28/202108:45SEEKInMed Pharma files applications to evaluate INM-755 for..
4/28/202107:30GLOBEInMed Pharmaceuticals Submits Clinical Trial Applications to..
4/27/202116:23EDGARCurrent Report Filing (8-k)
4/27/202107:30GLOBEInMed Pharmaceuticals Announces Voluntary Delisting from TSX
4/26/202107:30GLOBEInMed Pharmaceuticals Achieves 2g/L Cannabinoid Yield with..
3/16/202106:07EDGARProspectus Filed Pursuant to Rule 424(b)(3) (424b3)
3/16/202106:06EDGARNotice of Effectiveness (effect)
3/05/202112:55EDGARSecurities Registration: Employee Benefit Plan (s-8)
3/03/202118:00GLOBEInMed to Present at Virtual Conferences in March 2021
2/16/202107:30PRNUSInMed Announces Closing of US$4.5 Million Private Placement
2/16/202106:32EDGARCurrent Report Filing (8-k)
2/12/202112:36EDGARCurrent Report Filing (8-k)
2/11/202107:42SEEKInMed Pharmaceuticals reports Q4 results
2/11/202107:30PRNUSInMed Pharmaceuticals Reports Second Quarter Fiscal 2021..
2/11/202107:03EDGARQuarterly Report (10-q)
2/09/202116:05EDGARStatement of Ownership (sc 13g)
2/05/202121:00PRNUSInMed Pharmaceuticals to Report Second Quarter Fiscal 2021..
2/05/202109:34PRNUSInMed Announces US$4.5 Million Private Placement
1/20/202115:44EDGARCurrent Report Filing (8-k)
1/19/202114:43EDGARCurrent Report Filing (8-k)
1/19/202114:00PRNUSInMed Pharmaceuticals to Participate in 2021..
1/08/202107:30PRNUSInMed Announces Results of Second Phase 1 Clinical Trial of..
1/05/202116:52PRNUSInMed to Participate at Virtual Conferences in January 2021
12/18/202006:22EDGARStatement of Changes in Beneficial Ownership (4)
See more news about this stock »

Your Recent History
InMed Phar..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.